Watch our on-demand webinar:
Accelerating Cell Line Development
View webinar
About Us
Our Company
Executive Leadership
Locations
Global Facilities Network
Seattle
Boulder
Longmont
Copenhagen
Heidelberg
Milan
Chiba
Policies
COVID-19 Response
Environment, Health & Safety
Group Privacy Policies
Our Services
Offerings
Mammalian
Microbial
pDNA
Viral Vector
Cell Therapy
mRNA
Services
Tech Transfer
Process Development
Analytical Development
Formulation Development
Process Validation
cGMP Manufacturing
Quality Systems & Inspection Management
News & Resources
Press Releases
Events
Thought Leadership
Resources
Case Studies
Fact Sheets
Video Library
Media Kit
Careers
Job Openings
Life at a CDMO
Diversity, Equity & Inclusion
Seattle Team
Boulder Team
Longmont Team
Copenhagen Team
Heidelberg Team
Milan Team
Chiba Team
Search
Search
Toggle Menu
Search
Search
Toggle Menu
About Us
Toggle Menu
Our Company
Executive Leadership
Locations
Toggle Menu
Global Facilities Network
Seattle
Boulder
Longmont
Copenhagen
Heidelberg
Milan
Chiba
Policies
Toggle Menu
COVID-19 Response
Environment, Health & Safety
Group Privacy Policies
Our Services
Toggle Menu
Offerings
Toggle Menu
Mammalian
Microbial
pDNA
Viral Vector
Cell Therapy
mRNA
Services
Toggle Menu
Tech Transfer
Process Development
Analytical Development
Formulation Development
Process Validation
cGMP Manufacturing
Quality Systems & Inspection Management
News & Resources
Toggle Menu
Press Releases
Events
Thought Leadership
Resources
Toggle Menu
Case Studies
Fact Sheets
Video Library
Media Kit
Careers
Toggle Menu
Job Openings
Life at a CDMO
Diversity, Equity & Inclusion
Seattle Team
Boulder Team
Longmont Team
Copenhagen Team
Heidelberg Team
Milan Team
Chiba Team
Our Company
About Us
Our History
Mission & Values
Executive Leadership
Locations
Global Facilities Network
Seattle
Boulder
Longmont
Copenhagen
Heidelberg
Milan
Chiba
Policies
COVID-19 Policies
Environment, Health & Safety
Group Privacy Policies
Offerings
Mammalian
Microbial
pDNA
Viral Vector
Cell Therapy
mRNA
Services
Tech Transfer
Process Development
Analytical Development
Formulation Development
Process Validation
cGMP Manufacturing
Quality Systems & Inspection Management
Fact Sheets
Global Manufacturing Capabilities (PDF)
CHEF1
TM
Expression Technology (PDF)
Analytical, Formulation and Stability (PDF)
Process Development (PDF)
Cell Therapy Capabilities (PDF)
Viral Vector Capabilities (PDF)
Plasmid DNA Capabilities (PDF)
Messenger RNA Capabilities (PDF)
News
Press Releases
Events
Thought Leadership
Resources
Case Studies
Fact Sheets
Video Library
Media Kit
Join Us
Career Opportunities
What Drives Us
Life at a CDMO
Diversity, Equity and Inclusion
Meet Our Teams
Seattle
Boulder
Longmont
Copenhagen
Heidelberg
Milan
Chiba
Press Releases
Filter by Tag
Show All
Cell & Gene Therapy
Company News
Events
News
Partnership
Press Release
1 min read
AGC Biologics Enters into Partnership as a CDMO with Ono Pharmaceuticals to Manufacture Biopharmaceuticals at Clinical Development Stage
August 13, 2020 at 6:00 AM
News
Read More
2 min read
AGC Biologics Expands Partnership with Novavax
August 10, 2020 at 1:05 PM
News
Read More
1 min read
AGC to Complete the Acquisition of MolMed on July 31, 2020
July 27, 2020 at 7:00 PM
News
Read More
2 min read
AGC Biologics Collaborates with Molecular Partners AG to Develop Anti-COVID-19 DARPin® Program
July 8, 2020 at 10:00 PM
News
Read More
1 min read
AGC Biologics Expands Development Capacities for pDNA Services at Heidelberg Site
June 30, 2020 at 6:00 AM
News
Read More
2 min read
Calypso Biotech Completes CALY-002 Clinical Batch Manufacturing
June 18, 2020 at 4:00 AM
News
Read More
2 min read
Saiba AG Selects AGC Biologics to Develop and Produce COVID-19 Vaccine
June 16, 2020 at 4:00 AM
News
Read More
2 min read
Novavax Selects AGC Biologics to Manufacture Matrix-M™ Adjuvant for Novel COVID-19 Vaccine
June 3, 2020 at 4:00 AM
News
Read More
1 min read
AGC Biologics Acquires Commercial Facility, Expanding Global Service Offerings
June 1, 2020 at 3:00 PM
News
Read More
2 min read
Takara Bio Selects AGC Biologics as Manufacturer of Plasmid DNA Intermediate for a Vaccine Against COVID-19 (SARS-CoV-2)
May 20, 2020 at 11:00 PM
News
Read More
Prev
4
5
6
7
8
Next
